» Articles » PMID: 33227683

Hierarchical Cluster Analysis of Multimodal Imaging Data Identifies Brain Atrophy and Cognitive Patterns in Parkinson's Disease

Overview
Specialty Neurology
Date 2020 Nov 23
PMID 33227683
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is a heterogeneous condition. Cluster analysis based on cortical thickness has been used to define distinct patterns of brain atrophy in PD. However, the potential of other neuroimaging modalities, such as white matter (WM) fractional anisotropy (FA), which has also been demonstrated to be altered in PD, has not been investigated.

Objective: We aim to characterize PD subtypes using a multimodal clustering approach based on cortical and subcortical gray matter (GM) volumes and FA measures.

Methods: We included T1-weighted and diffusion-weighted MRI data from 62 PD patients and 33 healthy controls. We extracted mean GM volumes from 48 cortical and 17 subcortical regions using FSL-VBM, and the mean FA from 20 WM tracts using Tract-Based Spatial Statistics (TBSS). Hierarchical cluster analysis was performed with the PD sample using Ward's linkage method. Whole-brain voxel-wise intergroup comparisons of VBM and TBSS data were also performed using FSL. Neuropsychological and demographic statistical analyses were conducted using IBM SPSS Statistics 25.0.

Results: We identified three PD subtypes, with prominent differences in GM patterns and little WM involvement. One group (n = 15) with widespread cortical and subcortical GM volume and WM FA reductions and pronounced cognitive deficits; a second group (n = 21) with only cortical atrophy limited to frontal and temporal regions and more specific neuropsychological impairment, and a third group (n = 26) without detectable atrophy or cognition impairment.

Conclusion: Multimodal MRI data allows classifying PD patients into groups according to GM and WM patterns, which in turn are associated with the cognitive profile.

Citing Articles

Cluster-Based White Matter Signatures and the Risk of Dementia, Stroke, and Mortality in Community-Dwelling Adults.

Rosbergen M, Wolters F, Vinke E, Mattace-Raso F, Roshchupkin G, Ikram M Neurology. 2024; 103(7):e209864.

PMID: 39255426 PMC: 11399066. DOI: 10.1212/WNL.0000000000209864.


MRI subtypes in Parkinson's disease across diverse populations and clustering approaches.

Inguanzo A, Mohanty R, Poulakis K, Ferreira D, Segura B, Albrecht F NPJ Parkinsons Dis. 2024; 10(1):159.

PMID: 39152153 PMC: 11329719. DOI: 10.1038/s41531-024-00759-2.


A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.

Owens-Walton C, Nir T, Al-Bachari S, Ambrogi S, Anderson T, Aventurato I NPJ Parkinsons Dis. 2024; 10(1):151.

PMID: 39128907 PMC: 11317500. DOI: 10.1038/s41531-024-00758-3.


A multi-site study on sex differences in cortical thickness in non-demented Parkinson's disease.

Oltra J, Segura B, Strafella A, van Eimeren T, Ibarretxe-Bilbao N, Diez-Cirarda M NPJ Parkinsons Dis. 2024; 10(1):69.

PMID: 38521776 PMC: 10960793. DOI: 10.1038/s41531-024-00686-2.


Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.

Jellinger K Int J Mol Sci. 2024; 25(1).

PMID: 38203667 PMC: 10778722. DOI: 10.3390/ijms25010498.